Ozempic set to become more affordable, accessible in Canada — raising concerns of drug abuse
Ozempic, the popular weight-loss drug that made headlines in Hollywood, could become much cheaper and more widely distributed in Canada — after its manufacturer’s Canadian patent is set to expire in January 2026 — but that’s also sparking concern that it may result in more patients abusing the drug.